Evidence map›Paper›PMID 39576933›Full record

Observational studyRevista medica del Instituto Mexicano del Seguro Social2024

[Factors for spirometric impairment in survivors of severe coronavirus-19 disease].

José Luis Che-Morales, Juan Francisco Sánchez-Cruz, Rosa Esther Moo-Puc

Abstract readObservational StudyEnglish Abstract
In one paragraph

Observational study in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

José Luis Che-MoralesInstituto Mexicano del Seguro Social, Unidad Médica de Atención Ambulatoria 01, Departamento de Neumología e Inhaloterapia. Mérida, Yucatán, México.ORCID 0000-0002-5260-6325
Juan Francisco Sánchez-CruzInstituto Mexicano del Seguro Social, Órgano de Operación Administrativa Desconcentrada Estatal Yucatán, Departamento de Enseñanza Delegacional. Mérida, Yucatán, México.ORCID 0000-0002-4233-2957
Rosa Esther Moo-PucConsejo Nacional de Humanidades Ciencias y Tecnologías, Investigadores por México. Ciudad de México, México.ORCID 0000-0001-9204-6062

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients with severe coronavirus-19 disease (COVID-19) have more spirometric alterations, especially a restrictive pattern characterized by low forced vital capacity (FVC). Some variables associated with this alteration in lung function have been described, such as hypoxemia, vaccination and hand strength, which in turn are related to the magnitude of lung damage. Objective: To analyze different clinical variables and their association with alterations in spirometry in survivors of severe COVID-19. Material and methods: Retrospective and observational study of survivors of severe COVID-19 sent for their first spirometry, hand dynamometry, and 6-minute walk (6MW) in a secondary care unit during 2021. Results: 2 doses of SARS-CoV-2 vaccine were protective factor (odds ratio [OR]: 0.36, 95% CI [95% CI]: 0.1-0.8, p = 0.02) and hospitalization (> 15 days) was a risk factor for spirometric alterations (FVC < 80% of predicted) (OR: 3.0; 95% CI 1.3-6.8, p = 0.00); hand weakness, SpO2 desaturation > 4% in 6MW, and days of hospitalization were associated with low FVC. Conclusions: A hospitalization > 15 days and having 2 doses of vaccination are risk and protective factors, respectively, of having a low FVC. Days of hospitalization, vaccination status, and FVC allowed to identify clusters of severe COVID-19 survivors with greater deterioration.

Indexed as

COVID-19SpirometryAdultAgedCOVID-19 VaccinesFemaleHospitalizationHumansMaleMiddle AgedRetrospective StudiesRisk FactorsSeverity of Illness IndexSurvivorsVital CapacityCOVID-19 VaccinesCOVID-19SpirometryVaccination

Identifiers

PMID39576933
PMCPMC12413203

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.